Helix-forming aliphatic homo-δ-peptides foldamers based on conformational restriction of cyclopropane

01 September 2022, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Considerable effort has been directed toward developing artificial peptide-based foldamers. To date, however, detailed structural analysis of δ-peptide foldamers consisting of aliphatic δ-amino acids has not been reported. Herein, we rationally designed and stereoselectively synthesized aliphatic homo-δ-peptide foldamers forming a stable helical structure utilizing a chiral cyclopropane δ-amino acid as a monomer unit. Structural analysis of the homo-δ-peptides revealed that they form a stable 14-helical structure in solution. Furthermore, we successfully achieved X-ray crystallographic analysis of the homo-δ-peptides, showing their common right-handed 14-helical structures. The critical point is that the helical structures of these δ-peptides are theoretically predictable by calculations. This is the first example of aliphatic homo-δ-peptide foldamers forming a stable helical structure both in solution and crystal.

Keywords

δ-peptides
conformational restriction
helical structure
foldamer
X-ray crystal structure

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Figures S1–S10, Schemes S1–S6, Table S1, Summary of crystallographic data (Table S2), Synthetic procedures and characterization of compounds, Protocol of NMR structural calculation and MD simulation, and References
Actions
Title
X-ray crystal structure of N-Ac-tetramer 11a
Description
X-ray crystallographic analysis showed that the tetramer has a right-handed helical structure, in which all the possible 14-membered-ring hydrogen bonds are observed as anticipated from the molecular design.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.